Accessibility Menu
 
Prf Technologies logo

Prf Technologies

(NASDAQ) PRFX

Current Price$2.08
Market Cap$1.77M
Since IPO (2020)-100%
5 Year-100%
1 Year-82%
1 Month-25%

Prf Technologies Financials at a Glance

Market Cap

$1.77M

Revenue (TTM)

$0.00

Net Income (TTM)

$4.09M

EPS (TTM)

$-8.49

P/E Ratio

-0.25

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$2.08

Volume

828

Open

$2.06

Previous Close

$2.08

Daily Range

$2.06 - $2.08

52-Week Range

$1.80 - $17.95

PRFX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Prf Technologies

Industry

Pharmaceuticals

Employees

7

CEO

Ilan Hadar, MBA

Headquarters

Tel Aviv, 6745442, IL

PRFX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-34%

Return on Assets

-27%

Earnings Yield

-4.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.77M

Shares Outstanding

844.40K

Volume

828

Short Interest

0.00%

Avg. Volume

524.57K

Financials (TTM)

Gross Profit

$827.00K

Operating Income

$4.99M

EBITDA

$4.21M

Operating Cash Flow

$3.96M

Capital Expenditure

$2.00K

Free Cash Flow

$3.96M

Cash & ST Invst.

$4.17M

Total Debt

$21.00K

Prf Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.77M

N/A

Market Cap/Employee

$886.60K

N/A

Employees

2

N/A

Net Income

$1.16M

+84.2%

EBITDA

$1.09M

+85.1%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$4.12M

-2.3%

Accounts Receivable

$142.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$21.00K

-53.3%

Return on Assets

-26.68%

N/A

Return on Invested Capital

-34.00%

N/A

Free Cash Flow

$991.00K

+80.0%

Operating Cash Flow

$991.00K

+80.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UPCUniverse Pharmaceuticals Inc.
$3.16+15.75%
ATXIAvenue Therapeutics, Inc.
$0.35+20.69%
NCELNewcelX Ltd.
$2.25-4.04%
DRMADermata Therapeutics, Inc.
$1.29+7.50%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NOKNokia
$8.82+0.07%

Questions About PRFX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.